Annual ROE
-75.69%
-34.71%-84.70%
December 31, 2024
Summary
- As of March 10, 2025, SNDX annual return on equity is -75.69%, with the most recent change of -34.71% (-84.70%) on December 31, 2024.
- During the last 3 years, SNDX annual ROE has fallen by -83.24% (-1102.52%).
- SNDX annual ROE is now -121.82% below its all-time high of 346.89%, reached on December 31, 2014.
Performance
SNDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-74.65%
-7.32%-10.87%
December 31, 2024
Summary
- As of March 10, 2025, SNDX quarterly return on equity is -74.65%, with the most recent change of -7.32% (-10.87%) on December 31, 2024.
- Over the past year, SNDX quarterly ROE has stayed the same.
- SNDX quarterly ROE is now -104.78% below its all-time high of 1560.17%, reached on March 31, 2015.
Performance
SNDX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SNDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.7% | 0.0% |
| 3 y3 years | -1102.5% | 0.0% |
| 5 y5 years | +42.9% | 0.0% |
SNDX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1102.5% | at low | -880.0% | at low |
| 5 y | 5-year | -1102.5% | +42.9% | -880.0% | +33.7% |
| alltime | all time | -121.8% | +42.9% | -104.8% | +95.8% |
Syndax Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -75.69%(+84.7%) | -74.65%(+10.9%) |
| Sep 2024 | - | -67.33%(+14.2%) |
| Jun 2024 | - | -58.96%(+9.8%) |
| Mar 2024 | - | -53.69%(+13.7%) |
| Dec 2023 | -40.98%(+20.2%) | -47.23%(+7.3%) |
| Sep 2023 | - | -44.01%(+10.0%) |
| Jun 2023 | - | -40.02%(+3.3%) |
| Mar 2023 | - | -38.76%(+1.3%) |
| Dec 2022 | -34.10%(-551.7%) | -38.28%(+822.4%) |
| Sep 2022 | - | -4.15%(-1696.2%) |
| Jun 2022 | - | 0.26%(-95.2%) |
| Mar 2022 | - | 5.43%(-43.3%) |
| Dec 2021 | 7.55%(-114.6%) | 9.57%(-121.4%) |
| Sep 2021 | - | -44.69%(-4.8%) |
| Jun 2021 | - | -46.94%(-10.8%) |
| Mar 2021 | - | -52.64%(-11.2%) |
| Dec 2020 | -51.56%(-61.1%) | -59.29%(-27.4%) |
| Sep 2020 | - | -81.63%(-8.3%) |
| Jun 2020 | - | -89.03%(-20.9%) |
| Mar 2020 | - | -112.59%(+1.5%) |
| Dec 2019 | -132.43% | -110.94%(+4.0%) |
| Sep 2019 | - | -106.71%(+1.7%) |
| Jun 2019 | - | -104.94%(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -100.31%(+2.8%) |
| Dec 2018 | -94.00%(+45.7%) | -97.59%(+11.1%) |
| Sep 2018 | - | -87.82%(+14.1%) |
| Jun 2018 | - | -76.95%(+7.6%) |
| Mar 2018 | - | -71.53%(+9.9%) |
| Dec 2017 | -64.53%(+9.4%) | -65.08%(+13.2%) |
| Sep 2017 | - | -57.50%(+2.3%) |
| Jun 2017 | - | -56.20%(+12.3%) |
| Mar 2017 | - | -50.05%(+4.6%) |
| Dec 2016 | -58.97%(-25.4%) | -47.84%(+11.0%) |
| Sep 2016 | - | -43.11%(-4.2%) |
| Jun 2016 | - | -45.02%(-25.9%) |
| Mar 2016 | - | -60.78%(+73.2%) |
| Dec 2015 | -79.10%(-122.8%) | -35.09%(-49.1%) |
| Sep 2015 | - | -68.89%(-112.7%) |
| Jun 2015 | - | 541.23%(-65.3%) |
| Mar 2015 | - | 1560.17%(-187.5%) |
| Dec 2014 | 346.89%(-390.0%) | -1782.69%(+376.1%) |
| Sep 2014 | - | -374.43%(+73.1%) |
| Jun 2014 | - | -216.28%(+28.6%) |
| Mar 2014 | - | -168.17%(+40.6%) |
| Dec 2013 | -119.60%(-451.6%) | -119.60% |
| Dec 2012 | 34.02% | - |
FAQ
- What is Syndax Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual ROE year-on-year change?
- What is Syndax Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly ROE year-on-year change?
What is Syndax Pharmaceuticals annual return on equity?
The current annual ROE of SNDX is -75.69%
What is the all time high annual ROE for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual return on equity is 346.89%
What is Syndax Pharmaceuticals annual ROE year-on-year change?
Over the past year, SNDX annual return on equity has changed by -34.71% (-84.70%)
What is Syndax Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SNDX is -74.65%
What is the all time high quarterly ROE for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly return on equity is 1560.17%
What is Syndax Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SNDX quarterly return on equity has changed by 0.00% (0.00%)